Focused on the discovery and preclinical development of innovative biologics for unmet medical needs
Scientific Advisory Board
Greg Landes, Ph.D.
VP of R&D at Takeda
VP of Biotherapeutics at Lexicon Pharma
VP of R&D at Abgenix
PhD, University of Kansas
"At the scientific advisory board meeting, the Biosion management team revealed a deep understanding of creating antibody drug design goals for each program as a critical means to achieve superior antibody drugs. Furthermore, they demonstrated their strong technical capabilities in B-cell immortalization and drug screening to identify and recover rare antibodies that meet or exceed their drug design goals." — Dr. Greg Landes
Michael Karin, Ph.D.
Distinguished Professor of Pharmacology, UCSD
Member, National Academy Sciences
PhD, University of California, Los Angeles
"Biosion has the most impressive system for generation high quality therapeutic antibodies." — Dr. Michael Karin
Lei Zheng, MD, Ph.D.
Oncologist, Johns Hopkins University
PhD, University of Texas Health Science Center
MD, Peking Union Medical University
"Biosion has a strong innovative mind, a hardworking force, and a comprehensive pipeline." — Dr. Lei Zheng
Bing Su, Ph.D.
Chair, Department of Immunology and Microbiology,
Shanghai Jiao Tong University School of Medicine
PhD, Yale University
"My observation is that Biosion has a highly talented leadership team and innovative systems for producing high quality and broad spectrum therapeutic antibodies with a vision of becoming a global player." — Dr. Bing Su